Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa
Open Access
- 1 February 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (3), 377-386
- https://doi.org/10.1086/525260
Abstract
Background.In the African meningitis belt, Neisseria meningitidis serogroup W135 has emerged as a cause of epidemic disease. The establishment of W13Keywords
This publication has 33 references indexed in Scilit:
- Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, ChinaThe Lancet, 2006
- Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introductionThe Lancet, 2004
- Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000Emerging Infectious Diseases, 2002
- Development of vaccines against meningococcal diseaseThe Lancet, 2002
- Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, CameroonEmerging Infectious Diseases, 2002
- Comparison of Serogroup W-135 Meningococci Isolated in Sweden during a 23-Year Period and Those Associated with a Recent Hajj PilgrimageJournal of Clinical Microbiology, 2001
- Meningococcal DiseaseNew England Journal of Medicine, 2001
- Serogroup W135 meningococcal disease in Hajj pilgrimsThe Lancet, 2000
- Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.Emerging Infectious Diseases, 2000
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999